首页> 外文会议>International Conference on Big Data and Smart Computing >Analysis of genetic relationship of M81 and B95-in Epstein-Barr Virus: Comparison of M81 and B95-8 by using Apriori algorithm, decision tree, and support vector machine
【24h】

Analysis of genetic relationship of M81 and B95-in Epstein-Barr Virus: Comparison of M81 and B95-8 by using Apriori algorithm, decision tree, and support vector machine

机译:爱泼斯坦-巴尔病毒中M81和B95-的遗传关系分析:使用Apriori算法,决策树和支持向量机比较M81和B95-8

获取原文

摘要

Both M81 and B95-8 are distinct strains belonged to Epstein-Barr Virus (EBV). However, as M81's target cell is epithelial cell and that of B95-8 is B cell, and common EBV vaccine only causes an effect only on B95-8, we can recognize that these two EBVs have different characteristics. In this paper, we analyzed DNA sequence using three algorithms: Apriori, Decision Tree, and support vector machine to search the reason why these differences appear even though EBV is in the same classification scheme. DNA used in this analysis can be sorted into three categories: BZLF1 and BRLF1 which control overall stages of DNA synthesis, and BALF4 which produces gp110 protein which is a target of EBV vaccine. Finally, we also analyzed LMP1 and LMP2 which newly invented EBV vaccine recognizes as a target, and came to a conclusion that it is probable that the vaccine will work on both viruses due to their similarities observed through our study.
机译:M81和B95-8都是属于爱泼斯坦-巴尔病毒(EBV)的独特菌株。但是,由于M81的靶细胞是上皮细胞,而B95-8的靶细胞是B细胞,普通的EBV疫苗仅对B95-8产生作用,因此我们可以认识到这两种EBV具有不同的特性。在本文中,我们使用三种算法(Apriori,决策树和支持向量机)分析了DNA序列,以寻找即使EBV在同一分类方案中也出现这些差异的原因。用于此分析的DNA可以分为三类:控制DNA合成的整个阶段的BZLF1和BRLF1,以及产生gb110蛋白的BALF4,该蛋白是EBV疫苗的靶标。最后,我们还分析了新发明的EBV疫苗可识别为靶标的LMP1和LMP2,并得出结论,由于在我们的研究中观察到的相似性,该疫苗很可能对两种病毒都起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号